Unknown PHASE3 INTERVENTIONAL 2-arm NCT04363450

Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) (HCQPreP)

Hydroxychloroquine as Primary Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)

Sponsor: Lafayette General Health

Conditions COVID-19 Corona Virus Infection Healthcare Worker Hydroxychloroquine Prophylaxis Sars-CoV2 Wuhan Coronavirus

Interventions Hydroxychloroquine Placebo

Updated 6 times since 2020 Last updated: Aug 31, 2020 Started: Apr 27, 2020 Primary completion: Mar 31, 2021 Completion: Jun 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on COVID-19 and Corona Virus Infection, this trial is ongoing. The trial is conducted by Lafayette General Health and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

May 2020 — Oct 2020 [monthly]

Recruiting PHASE3

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lafayette General Health
Louisiana State University Health Sciences Center in New Orleans
University of Louisiana at Lafayette

Data source: Louisiana State University Health Sciences Center in New Orleans

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lafayette, United States